Press release
North American Osteoarthritis Therapeutics Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027
North American osteoarthritis therapeutics market is estimated to grow at a CAGR of 8.1% during the forecast period. The rising adoption of viscosupplementation agents is one of the key factors accelerating market growth. Viscosupplementation agents have been gaining significance in the region owing to the rising incidences of knee osteoarthritis. Knee osteoarthritis is one of the major causes of disability in the US. The condition develops slowly, and pain worsens with time. The rising trend towards non-surgical alternatives is a crucial factor that is driving the demand for viscosupplementation agents. It is a non-surgical medical procedure in which a hyaluronic acid (HA) is injected into a person's knee.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-osteoarthritis-therapeutics-market
Viscosupplements, including Euflexxa, Orthovisc, Hyal-gan, and Synvisc, are injections that are approved by the FDA for osteoarthritis joint pain treatment. The US FDA approvals for viscosupplementation agents are offering an opportunity for the rising adoption of Viscosupplementation agents. For instance, in December 2019, Fidia Farmaceutici S.p.A., launched TRILURON (sodium hyaluronate) in the US. It is an HA-based intra-articular viscosupplement designed for pain treatment of knee osteoarthritis in patients who failed to respond sufficiently to simple analgesics (including acetaminophen) and conservative non-pharmacologic therapy.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-osteoarthritis-therapeutics-market
Scope of the North American Osteoarthritis Therapeutics Market
North American Osteoarthritis Therapeutics Market-Segmentation
By Anatomy
• Knee
• Ankle
• Hip
• Hand
• Spine
By Drug Type
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Viscosupplementation Agents
• Corticosteroids
• Analgesics
North American Osteoarthritis Therapeutics Market– Segment by Country
• US
• Canada
Company Profiles
• Abbott Laboratories
• Anika Therapeutics, Inc.
• Assertio Therapeutics, Inc.
• Bayer AG
• Bioventus LLC
• Eli Lilly and Co.
• Flexion Therapeutics
• GlaxoSmithKline plc
• Iroko Pharmaceuticals, Inc.
• Johnson & Johnson
• OrthogenRx, Inc.
• Pfizer Inc.
• Sanofi S.A.
• Zimmer Biomet Holdings, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-osteoarthritis-therapeutics-market
Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Osteoarthritis Therapeutics Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027 here
News-ID: 2283662 • Views: …
More Releases from Orion Market Research
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
